Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 25 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2029, rising at a market growth of 4.4% CAGR during the forecast period (2023-2029).

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

This report studies the global Tuberculosis Prevention and Treatment Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tuberculosis Prevention and Treatment Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tuberculosis Prevention and Treatment Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tuberculosis Prevention and Treatment Vaccine total production and demand, 2018-2029, (K Units)
Global Tuberculosis Prevention and Treatment Vaccine total production value, 2018-2029, (USD Million)
Global Tuberculosis Prevention and Treatment Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tuberculosis Prevention and Treatment Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tuberculosis Prevention and Treatment Vaccine domestic production, consumption, key domestic manufacturers and share
Global Tuberculosis Prevention and Treatment Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tuberculosis Prevention and Treatment Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tuberculosis Prevention and Treatment Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Tuberculosis Prevention and Treatment Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tuberculosis Prevention and Treatment Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Tuberculosis Prevention and Treatment Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Tuberculosis Prevention and Treatment Vaccine Market, Segmentation by Type
Immune Vaccine
Therapy Vaccine

Global Tuberculosis Prevention and Treatment Vaccine Market, Segmentation by Application
Self-Procurement
UNICEF
Other

Companies Profiled:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen

Key Questions Answered
1. How big is the global Tuberculosis Prevention and Treatment Vaccine market?
2. What is the demand of the global Tuberculosis Prevention and Treatment Vaccine market?
3. What is the year over year growth of the global Tuberculosis Prevention and Treatment Vaccine market?
4. What is the production and production value of the global Tuberculosis Prevention and Treatment Vaccine market?
5. Who are the key producers in the global Tuberculosis Prevention and Treatment Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Tuberculosis Prevention and Treatment Vaccine Introduction
    1.2 World Tuberculosis Prevention and Treatment Vaccine Supply & Forecast
        1.2.1 World Tuberculosis Prevention and Treatment Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Tuberculosis Prevention and Treatment Vaccine Production (2018-2029)
        1.2.3 World Tuberculosis Prevention and Treatment Vaccine Pricing Trends (2018-2029)
    1.3 World Tuberculosis Prevention and Treatment Vaccine Production by Region (Based on Production Site)
        1.3.1 World Tuberculosis Prevention and Treatment Vaccine Production Value by Region (2018-2029)
        1.3.2 World Tuberculosis Prevention and Treatment Vaccine Production by Region (2018-2029)
        1.3.3 World Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Tuberculosis Prevention and Treatment Vaccine Production (2018-2029)
        1.3.5 Europe Tuberculosis Prevention and Treatment Vaccine Production (2018-2029)
        1.3.6 China Tuberculosis Prevention and Treatment Vaccine Production (2018-2029)
        1.3.7 Japan Tuberculosis Prevention and Treatment Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Tuberculosis Prevention and Treatment Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Tuberculosis Prevention and Treatment Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Tuberculosis Prevention and Treatment Vaccine Demand (2018-2029)
    2.2 World Tuberculosis Prevention and Treatment Vaccine Consumption by Region
        2.2.1 World Tuberculosis Prevention and Treatment Vaccine Consumption by Region (2018-2023)
        2.2.2 World Tuberculosis Prevention and Treatment Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)
    2.4 China Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)
    2.5 Europe Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)
    2.6 Japan Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)
    2.7 South Korea Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)
    2.8 ASEAN Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)
    2.9 India Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029)

3 World Tuberculosis Prevention and Treatment Vaccine Manufacturers Competitive Analysis
    3.1 World Tuberculosis Prevention and Treatment Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Tuberculosis Prevention and Treatment Vaccine Production by Manufacturer (2018-2023)
    3.3 World Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Tuberculosis Prevention and Treatment Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Tuberculosis Prevention and Treatment Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Tuberculosis Prevention and Treatment Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Tuberculosis Prevention and Treatment Vaccine in 2022
    3.6 Tuberculosis Prevention and Treatment Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Tuberculosis Prevention and Treatment Vaccine Market: Region Footprint
        3.6.2 Tuberculosis Prevention and Treatment Vaccine Market: Company Product Type Footprint
        3.6.3 Tuberculosis Prevention and Treatment Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Value Comparison
        4.1.1 United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Comparison
        4.2.1 United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Tuberculosis Prevention and Treatment Vaccine Consumption Comparison
        4.3.1 United States VS China: Tuberculosis Prevention and Treatment Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Tuberculosis Prevention and Treatment Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Tuberculosis Prevention and Treatment Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Tuberculosis Prevention and Treatment Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production (2018-2023)
    4.5 China Based Tuberculosis Prevention and Treatment Vaccine Manufacturers and Market Share
        4.5.1 China Based Tuberculosis Prevention and Treatment Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production (2018-2023)
    4.6 Rest of World Based Tuberculosis Prevention and Treatment Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Tuberculosis Prevention and Treatment Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Tuberculosis Prevention and Treatment Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Immune Vaccine
        5.2.2 Therapy Vaccine
    5.3 Market Segment by Type
        5.3.1 World Tuberculosis Prevention and Treatment Vaccine Production by Type (2018-2029)
        5.3.2 World Tuberculosis Prevention and Treatment Vaccine Production Value by Type (2018-2029)
        5.3.3 World Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Tuberculosis Prevention and Treatment Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Self-Procurement
        6.2.2 UNICEF
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Tuberculosis Prevention and Treatment Vaccine Production by Application (2018-2029)
        6.3.2 World Tuberculosis Prevention and Treatment Vaccine Production Value by Application (2018-2029)
        6.3.3 World Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Japan BCG Lab
        7.2.1 Japan BCG Lab Details
        7.2.2 Japan BCG Lab Major Business
        7.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Japan BCG Lab Recent Developments/Updates
        7.2.6 Japan BCG Lab Competitive Strengths & Weaknesses
    7.3 Serum Institute of India
        7.3.1 Serum Institute of India Details
        7.3.2 Serum Institute of India Major Business
        7.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Serum Institute of India Recent Developments/Updates
        7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
    7.4 AJ Vaccines
        7.4.1 AJ Vaccines Details
        7.4.2 AJ Vaccines Major Business
        7.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 AJ Vaccines Recent Developments/Updates
        7.4.6 AJ Vaccines Competitive Strengths & Weaknesses
    7.5 BioFarma
        7.5.1 BioFarma Details
        7.5.2 BioFarma Major Business
        7.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 BioFarma Recent Developments/Updates
        7.5.6 BioFarma Competitive Strengths & Weaknesses
    7.6 GreenSignal Bio Pharma
        7.6.1 GreenSignal Bio Pharma Details
        7.6.2 GreenSignal Bio Pharma Major Business
        7.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 GreenSignal Bio Pharma Recent Developments/Updates
        7.6.6 GreenSignal Bio Pharma Competitive Strengths & Weaknesses
    7.7 China National Biotec
        7.7.1 China National Biotec Details
        7.7.2 China National Biotec Major Business
        7.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 China National Biotec Recent Developments/Updates
        7.7.6 China National Biotec Competitive Strengths & Weaknesses
    7.8 Biomed Lublin
        7.8.1 Biomed Lublin Details
        7.8.2 Biomed Lublin Major Business
        7.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Biomed Lublin Recent Developments/Updates
        7.8.6 Biomed Lublin Competitive Strengths & Weaknesses
    7.9 Taj Pharmaceuticals
        7.9.1 Taj Pharmaceuticals Details
        7.9.2 Taj Pharmaceuticals Major Business
        7.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Taj Pharmaceuticals Recent Developments/Updates
        7.9.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 Ataulpho de Paiva
        7.10.1 Ataulpho de Paiva Details
        7.10.2 Ataulpho de Paiva Major Business
        7.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Ataulpho de Paiva Recent Developments/Updates
        7.10.6 Ataulpho de Paiva Competitive Strengths & Weaknesses
    7.11 IVAC
        7.11.1 IVAC Details
        7.11.2 IVAC Major Business
        7.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 IVAC Recent Developments/Updates
        7.11.6 IVAC Competitive Strengths & Weaknesses
    7.12 Queen Saovabha Mem. Inst
        7.12.1 Queen Saovabha Mem. Inst Details
        7.12.2 Queen Saovabha Mem. Inst Major Business
        7.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
        7.12.6 Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
    7.13 Microgen
        7.13.1 Microgen Details
        7.13.2 Microgen Major Business
        7.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services
        7.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Microgen Recent Developments/Updates
        7.13.6 Microgen Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Tuberculosis Prevention and Treatment Vaccine Industry Chain
    8.2 Tuberculosis Prevention and Treatment Vaccine Upstream Analysis
        8.2.1 Tuberculosis Prevention and Treatment Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Tuberculosis Prevention and Treatment Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Tuberculosis Prevention and Treatment Vaccine Production Mode
    8.6 Tuberculosis Prevention and Treatment Vaccine Procurement Model
    8.7 Tuberculosis Prevention and Treatment Vaccine Industry Sales Model and Sales Channels
        8.7.1 Tuberculosis Prevention and Treatment Vaccine Sales Model
        8.7.2 Tuberculosis Prevention and Treatment Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Tuberculosis Prevention and Treatment Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Tuberculosis Prevention and Treatment Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Tuberculosis Prevention and Treatment Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Tuberculosis Prevention and Treatment Vaccine Production by Region (2018-2023) & (K Units)
    Table 7. World Tuberculosis Prevention and Treatment Vaccine Production by Region (2024-2029) & (K Units)
    Table 8. World Tuberculosis Prevention and Treatment Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Tuberculosis Prevention and Treatment Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Tuberculosis Prevention and Treatment Vaccine Major Market Trends
    Table 13. World Tuberculosis Prevention and Treatment Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Tuberculosis Prevention and Treatment Vaccine Consumption by Region (2018-2023) & (K Units)
    Table 15. World Tuberculosis Prevention and Treatment Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Tuberculosis Prevention and Treatment Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Tuberculosis Prevention and Treatment Vaccine Producers in 2022
    Table 18. World Tuberculosis Prevention and Treatment Vaccine Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Tuberculosis Prevention and Treatment Vaccine Producers in 2022
    Table 20. World Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Tuberculosis Prevention and Treatment Vaccine Company Evaluation Quadrant
    Table 22. World Tuberculosis Prevention and Treatment Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Tuberculosis Prevention and Treatment Vaccine Production Site of Key Manufacturer
    Table 24. Tuberculosis Prevention and Treatment Vaccine Market: Company Product Type Footprint
    Table 25. Tuberculosis Prevention and Treatment Vaccine Market: Company Product Application Footprint
    Table 26. Tuberculosis Prevention and Treatment Vaccine Competitive Factors
    Table 27. Tuberculosis Prevention and Treatment Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Tuberculosis Prevention and Treatment Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Tuberculosis Prevention and Treatment Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Tuberculosis Prevention and Treatment Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Tuberculosis Prevention and Treatment Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Tuberculosis Prevention and Treatment Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Market Share (2018-2023)
    Table 37. China Based Tuberculosis Prevention and Treatment Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Tuberculosis Prevention and Treatment Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Market Share (2018-2023)
    Table 47. World Tuberculosis Prevention and Treatment Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Tuberculosis Prevention and Treatment Vaccine Production by Type (2018-2023) & (K Units)
    Table 49. World Tuberculosis Prevention and Treatment Vaccine Production by Type (2024-2029) & (K Units)
    Table 50. World Tuberculosis Prevention and Treatment Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Tuberculosis Prevention and Treatment Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Tuberculosis Prevention and Treatment Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Tuberculosis Prevention and Treatment Vaccine Production by Application (2018-2023) & (K Units)
    Table 56. World Tuberculosis Prevention and Treatment Vaccine Production by Application (2024-2029) & (K Units)
    Table 57. World Tuberculosis Prevention and Treatment Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Tuberculosis Prevention and Treatment Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Merck Basic Information, Manufacturing Base and Competitors
    Table 62. Merck Major Business
    Table 63. Merck Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 64. Merck Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Merck Recent Developments/Updates
    Table 66. Merck Competitive Strengths & Weaknesses
    Table 67. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
    Table 68. Japan BCG Lab Major Business
    Table 69. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 70. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Japan BCG Lab Recent Developments/Updates
    Table 72. Japan BCG Lab Competitive Strengths & Weaknesses
    Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 74. Serum Institute of India Major Business
    Table 75. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 76. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Serum Institute of India Recent Developments/Updates
    Table 78. Serum Institute of India Competitive Strengths & Weaknesses
    Table 79. AJ Vaccines Basic Information, Manufacturing Base and Competitors
    Table 80. AJ Vaccines Major Business
    Table 81. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 82. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. AJ Vaccines Recent Developments/Updates
    Table 84. AJ Vaccines Competitive Strengths & Weaknesses
    Table 85. BioFarma Basic Information, Manufacturing Base and Competitors
    Table 86. BioFarma Major Business
    Table 87. BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 88. BioFarma Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. BioFarma Recent Developments/Updates
    Table 90. BioFarma Competitive Strengths & Weaknesses
    Table 91. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
    Table 92. GreenSignal Bio Pharma Major Business
    Table 93. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 94. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. GreenSignal Bio Pharma Recent Developments/Updates
    Table 96. GreenSignal Bio Pharma Competitive Strengths & Weaknesses
    Table 97. China National Biotec Basic Information, Manufacturing Base and Competitors
    Table 98. China National Biotec Major Business
    Table 99. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 100. China National Biotec Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. China National Biotec Recent Developments/Updates
    Table 102. China National Biotec Competitive Strengths & Weaknesses
    Table 103. Biomed Lublin Basic Information, Manufacturing Base and Competitors
    Table 104. Biomed Lublin Major Business
    Table 105. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 106. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Biomed Lublin Recent Developments/Updates
    Table 108. Biomed Lublin Competitive Strengths & Weaknesses
    Table 109. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 110. Taj Pharmaceuticals Major Business
    Table 111. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 112. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Taj Pharmaceuticals Recent Developments/Updates
    Table 114. Taj Pharmaceuticals Competitive Strengths & Weaknesses
    Table 115. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
    Table 116. Ataulpho de Paiva Major Business
    Table 117. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 118. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Ataulpho de Paiva Recent Developments/Updates
    Table 120. Ataulpho de Paiva Competitive Strengths & Weaknesses
    Table 121. IVAC Basic Information, Manufacturing Base and Competitors
    Table 122. IVAC Major Business
    Table 123. IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 124. IVAC Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. IVAC Recent Developments/Updates
    Table 126. IVAC Competitive Strengths & Weaknesses
    Table 127. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
    Table 128. Queen Saovabha Mem. Inst Major Business
    Table 129. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 130. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Queen Saovabha Mem. Inst Recent Developments/Updates
    Table 132. Microgen Basic Information, Manufacturing Base and Competitors
    Table 133. Microgen Major Business
    Table 134. Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services
    Table 135. Microgen Tuberculosis Prevention and Treatment Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 136. Global Key Players of Tuberculosis Prevention and Treatment Vaccine Upstream (Raw Materials)
    Table 137. Tuberculosis Prevention and Treatment Vaccine Typical Customers
    Table 138. Tuberculosis Prevention and Treatment Vaccine Typical Distributors
List of Figure
    Figure 1. Tuberculosis Prevention and Treatment Vaccine Picture
    Figure 2. World Tuberculosis Prevention and Treatment Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Tuberculosis Prevention and Treatment Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Tuberculosis Prevention and Treatment Vaccine Production (2018-2029) & (K Units)
    Figure 5. World Tuberculosis Prevention and Treatment Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Tuberculosis Prevention and Treatment Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Tuberculosis Prevention and Treatment Vaccine Production (2018-2029) & (K Units)
    Figure 9. Europe Tuberculosis Prevention and Treatment Vaccine Production (2018-2029) & (K Units)
    Figure 10. China Tuberculosis Prevention and Treatment Vaccine Production (2018-2029) & (K Units)
    Figure 11. Japan Tuberculosis Prevention and Treatment Vaccine Production (2018-2029) & (K Units)
    Figure 12. Tuberculosis Prevention and Treatment Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 15. World Tuberculosis Prevention and Treatment Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 17. China Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 18. Europe Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 19. Japan Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 22. India Tuberculosis Prevention and Treatment Vaccine Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Tuberculosis Prevention and Treatment Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Tuberculosis Prevention and Treatment Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Tuberculosis Prevention and Treatment Vaccine Markets in 2022
    Figure 26. United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Tuberculosis Prevention and Treatment Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Tuberculosis Prevention and Treatment Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Tuberculosis Prevention and Treatment Vaccine Production Market Share 2022
    Figure 32. World Tuberculosis Prevention and Treatment Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Type in 2022
    Figure 34. Immune Vaccine
    Figure 35. Therapy Vaccine
    Figure 36. World Tuberculosis Prevention and Treatment Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Tuberculosis Prevention and Treatment Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Application in 2022
    Figure 41. Self-Procurement
    Figure 42. UNICEF
    Figure 43. Other
    Figure 44. World Tuberculosis Prevention and Treatment Vaccine Production Market Share by Application (2018-2029)
    Figure 45. World Tuberculosis Prevention and Treatment Vaccine Production Value Market Share by Application (2018-2029)
    Figure 46. World Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Tuberculosis Prevention and Treatment Vaccine Industry Chain
    Figure 48. Tuberculosis Prevention and Treatment Vaccine Procurement Model
    Figure 49. Tuberculosis Prevention and Treatment Vaccine Sales Model
    Figure 50. Tuberculosis Prevention and Treatment Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Tuberculosis Prevention and Treatment Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Tuberculosis Prevention and Treatment Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

Global Tuberculosis Prevention and Treatment Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Tuberculosis Prevention and Treatment Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Tuberculosis Prevention and Treatment Vaccine market size was valued at USD 76 million in 2023 and is forecast to a readjusted size of USD 102.9 million by 2030 with a CAGR of 4.4% during review period.

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2024-2030

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

Product Tags

Tuberculosis Prevention and Treatment Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>